Lakefront Biotherapeutics repurchases shares
- Repurchased 126,322 shares between Oct 5-9, 2026
- Total cost was $3.3M
- Average price paid was $26.26
Every EDGAR filing for Lakefront Biotherapeutics NV (GLPGF), newest first, with AI summaries and stories.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Ownership stake disclosure by Madison Avenue Partners, LP
Madison Avenue Partners, LP, filed by